Development prospect of Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.

Since its establishment, the company has always regarded new product development and technological innovation as the strategic task of enterprise development, especially the research and development of traditional Chinese medicine preparations as the top priority. Traditional Chinese medicine preparations have a very broad sales market at home and abroad. Traditional Chinese medicine preparation has become a breakthrough for China's high-tech pharmaceutical products to go to the world because of its good curative effect and little toxic and side effects. Our company has jointly developed traditional Chinese medicine preparations with Shanghai Second Military Medical University, Shenyang Pharmaceutical University and other scientific research institutes, which is at the leading level in the industrialized production of traditional Chinese medicine. At present, the fist products produced by our company include the national second-class new drug cilnidipine tablets, the national traditional Chinese medicine protection variety Guanxinning injection, Shuxuening injection and Yixintong tablets. Five new varieties of traditional Chinese medicine have been registered and declared, among which the traditional Chinese medicine preparations with independent intellectual property rights include Astragaloside Sodium Chloride Injection, Yixintong Freeze-dried Preparation and Shuxuening Freeze-dried Preparation. The above three varieties are expected to be put into production one after another in 20 10 years, with an additional output value of 10 million yuan and an additional profit and tax of 30 million yuan.